AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis

Jino Park(University of Louisville), William Tse(University of Louisville), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Elena N. Pugacheva(West Virginia University), Silvia T. Bunting(Emory University), Michaela Schlederer(Ludwig Boltzmann Institute for Cancer Research), Chunyan Ji(Nanjing University of Chinese Medicine), Sebastian Hofbauer(Humboldt-Universität zu Berlin), Joseph Addison(West Virginia University), Lukas Kenner(University of Veterinary Medicine Vienna), Olaf Merkel(University of Veterinary Medicine Vienna), Scot C. Remick(University Hospitals of Cleveland), Kevin D. Bunting(Emory University), Laura F. Gibson(West Virginia University), Alexey V. Ivanov(Linguistics University of Nizhny Novgorod), Yon Rojanasakul(West Virginia University), Martin Schreiber(Medical University of Vienna), Martin Bilban(Medical University of Vienna), Soo‐Jin Kim(University of Louisville), Gang Huang(The University of Texas at San Antonio Health Science Center), Zhengqi Wang(Emory University), Jie Zou(Qilu Hospital of Shandong University), Menachem Shoham(University School), Ryan J. Ice(West Virginia University), Richard Moriggl(University of Salzburg)
Oncotarget
June 7, 2015
Cited by 40


Related Papers